Related Experiment Video

Updated: Jun 23, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Clinical decision rules for evaluating meningitis in children

François Dubos1, Alain Martinot, Dominique Gendrel

  • 1Department of Pediatric Emergencies and Infectious Diseases, Roger-Salengro Hospital, Lille University Hospital, Lille, France.

Current Opinion in Neurology
|April 22, 2009
PubMed
Abstract

Insights

Distinguishing bacterial from aseptic meningitis in children is challenging. New clinical decision rules show promise for accurate bedside diagnosis, potentially reducing unnecessary hospitalizations and antibiotic use.

Area of Science:

  • Pediatric infectious diseases
  • Clinical decision making
  • Diagnostic accuracy

Background:

  • Differentiating bacterial and aseptic meningitis in children presents diagnostic challenges.
  • Current guidelines advocate broad antibiotic use pending cerebrospinal fluid (CSF) culture results, leading to overuse in aseptic cases.
  • Clinical decision rules aim for early, accurate differentiation to optimize treatment and resource allocation.

Purpose of the Study:

  • To review the performance and validation of clinical decision rules for distinguishing bacterial from aseptic meningitis in children.
  • To identify reliable predictors for early diagnosis post-Haemophilus influenzae vaccination.
  • To assess the utility of rules meeting criteria for sensitivity, specificity, and bedside application.

Main Methods:

  • Systematic review of decision rules proposed after the introduction of Haemophilus influenzae vaccination.
  • Evaluation of rule validation levels and performance metrics.
  • Identification of the most validated predictive markers, including serum procalcitonin.

Main Results:

  • Most reviewed decision rules exhibit incomplete or lacking validation.
  • Serum procalcitonin level is identified as the single best validated predictive marker.
  • Two promising rules demonstrate high sensitivity and specificity in retrospective validation.

Conclusions:

  • Two clinical decision rules show significant promise for differentiating bacterial and aseptic meningitis in children.
  • These rules meet key criteria for clinical utility and can be cautiously applied.
  • Prospective multicenter validation studies are needed to confirm findings and guide broader implementation.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...